Oxford Centre for Early Cancer Detection Symposium 2020 - registration open! On Thursday 26th March at Worcester College the Oxford Centre for Early Cancer Detection will be showcasing a selection of Oxford's most exciting early cancer detection projects and you can hear about opportunities for how you can apply your research to this burgeoning field. This free event is for members of Oxford University and OUHFT only. Registration closes on 10th March.
An Advanced Personalised Therapeutics in Gynaecological Cancers Symposium is taking place at St Hugh’s College on 21 February 2020, to which you are all welcome to attend. Registration is free but only limited spaces are available. To register, please go to: https://forms.gle/T9ZKFF7Ttxctw1HYA This will be a full day meeting with a start of registration at 8.30 am and a close at 6 pm. For a description of the symposium and a list of confirmed speakers, please see this document. The full program of the symposium will be uploaded soon to the registration web page.
Professor Chas Bountra is interested in identifying and validating target proteins for drug discovery. Various technologies and strategies have allowed him to progress promising clinical candidates into Phase I, II, III studies, and to market. These new drugs offer novel treatments for neurodegenerative and gastrointestinal diseases, as well as pain disorders.
Many congratulations to Prof Alison Simmons, who has been awarded a Wellcome Trust Investigator Award. Alison Simmons is a Professor of Gastroenterology in NDM and the MRC Human Immunology Unit, and was recently elected a Fellow of the Academy of Medical Sciences. The Simmons lab works on Inflammatory Bowel Disease (IBD), a debilitating condition that affects more than 300,000 people in the UK. In IBD, the protective barrier that separates gut luminal microbes from the mucosal immune system is disrupted, leading to inflammation.
A specialist technique used to study drugs has been completed for the first time during an outbreak of Ebola virus disease. This study used pharmacokinetics – the measurement of the change in drug concentration in a person over time – to study an experimental drug for the treatment of Ebola virus disease during the 2015 outbreak in Sierra Leone.